title: Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone).
authors.affiliation: American Cancer Society, Atlanta, GA 30303, USA. victor.vogel@cancer.org
authors.forename: Victor G
authors.initials: VG
authors.lastname: Vogel